Genetics
News, opinions and meeting coverage in genetics.
— RNAi drug led to modest changes in disability, severity, and quality of life over 5 years
Latest in Genetics
Clinical utility of the FDA-approved test isn't clear, researchers say
However, FDA approval isn't expected soon due to quirk in earlier results
Antisense oligonucleotide olezarsen slashes high triglycerides
Crinecerfont reduces excessive adrenal androgen production, lowering glucocorticoid dose
Antisense oligonucleotide olezarsen slashes high triglycerides
Crinecerfont reduces excessive adrenal androgen production, lowering glucocorticoid dose
More in Genetics
But more diverse studies have found more genomic links to seizure conditions
Also in TTHealthWatch: U.S. drug prices under Medicare's price negotiation system
Nearly half of women with unusual or nonreportable cfDNA-sequencing results had cancer
Symptom onset was later; rate of worsening was slower
Agency is evaluating the need for further regulatory action
Also in TTHealthWatch: genetic testing of couples planning pregnancy
Australian study explored screening for hundreds of genetic conditions
In middle-age and older adults, high cardiorespiratory fitness was linked with better cognition
Phase I results show "big improvement" for what is usually progressive hypertrophy, expert says
No adverse events resulted in treatment discontinuation
Novel treatment is indicated for children and adults with the rare disorder
These eight specialties earn the least, with many averaging less than $300k per year
Observational study points to genetic risk allele dose-response
